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Prions are a group of proteins that can adopt a spectrum of metastable conformations in
vivo. These alternative states change protein function and are self-replicating and transmis-
sible, creating protein-based elements of inheritance and infectivity. Prion conformational
flexibility is encoded in the amino acid composition and sequence of the protein, which dic-
tate its ability not only to form an ordered aggregate known as amyloid but also to maintain
and transmit this structure in vivo. But, while we can effectively predict amyloid propensity
in vitro, the mechanism by which sequence elements promote prion propagation in vivo
remains unclear. In yeast, propagation of the [PSI+] prion, the amyloid form of the Sup35
protein, has been linked to an oligopeptide repeat region of the protein. Here, we demon-
strate that this region is composed of separable functional elements, the repeats them-
selves and a repeat proximal region, which are both required for efficient prion propagation.
Changes in the numbers of these elements do not alter the physical properties of Sup35
amyloid, but their presence promotes amyloid fragmentation, and therefore maintenance,
by molecular chaperones. Rather than acting redundantly, our observations suggest that
these sequence elements make complementary contributions to prion propagation, with
the repeat proximal region promoting chaperone binding to and the repeats promoting
chaperone processing of Sup35 amyloid.
Author Summary
Protein misfolding and assembly into ordered aggregates known as amyloid has emerged
as a novel mechanism for regulation of protein function. In the case of prion proteins, the
resulting amyloid is transmissible, creating protein-based elements of infectivity and
inheritance. These unusual properties are linked to the amino acid composition and
sequence of the protein, which confer both conformational flexibility and persistence in
PLOS Genetics | DOI:10.1371/journal.pgen.1006417 November 4, 2016 1 / 30
a11111
OPENACCESS
Citation: Langlois CR, Pei F, Sindi SS, Serio TR
(2016) Distinct Prion Domain Sequences Ensure
Efficient Amyloid Propagation by Promoting
Chaperone Binding or Processing In Vivo. PLoS
Genet 12(11): e1006417. doi:10.1371/journal.
pgen.1006417
Editor: Mick F. Tuite, University of Kent, UNITED
KINGDOM
Received: June 27, 2016
Accepted: October 10, 2016
Published: November 4, 2016
Copyright: © 2016 Langlois et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: These studies were funded by grants
from NIH/NIGMS to TRS (R01 GM069802, R35
GM118042) and CRL (F31 GM099383). The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
vivo, the latter of which occurs throughmechanisms that are currently poorly understood.
Here, we address this open question by studying a region of the yeast prion Sup35 that has
been genetically linked to persistence.We find that this region is composed of two separa-
ble elements that are both required for efficient persistence of the amyloid. These elements
do not contribute to amyloid stability. Rather, they promote distinct aspects of its func-
tional interactions with molecular chaperones, which are required for efficient conforma-
tional self-replication and transmission.
Introduction
The ability of some proteins to adopt alternative conformations expands the functional range
of the proteome by allowing individual proteins to access multiple conformers. For a unique
and expanding class of proteins, these conformational transitions are extensive and lead to the
assembly of the protein into ordered, linear, β-sheet-rich aggregates, known as amyloid [1].
The amyloid conformation is self-perpetuating, allowing the activity of the alternative
conformer to dominate, and in the case of a subset of amyloids known as prions, to become
transmissible [2].
These alternative conformational states are often associated with new phenotypes, arising
from either the loss of normal functions or the gain of new functions for the proteins [2].
Indeed, amyloids and prions contribute both to normal cellular homeostasis, regulating gene
expression, immunity, memory, organelle biogenesis, and ultrastructure [2–6], and to the dis-
ruption of this balance through diseases, including neurodegeneration,Type II diabetes, and
familial hypertension [1]. But, these biological consequences only arise because the amyloid
structure, once it appears, can persist in vivo. One component of this persistence, is the ability
of the linear amyloid fibers to template the refolding of normal conformers of the same protein
into the alternative state through interactions at the ends of the aggregates [1]. This propensity
to undergo self-templated conformational replication is an inherent property of each protein,
dictated by the composition and sequence of its amino acids, typically in one region of the pro-
tein that is predicted to be intrinsically disordered [7]. These regions tend to be rich in gluta-
mine and/or asparagine (Q/N), which promote aggregation via their propensity to form
hydrogen-bonding networks [8–10], and depleted for prolines and charged amino acids, which
are thought to act as amyloid breakers [11]. As such, the spacing of these latter residues, when
present, is an important predictor of amyloidogenicity [11,12].
Beyond the formation of the amyloid structure, the amplification and persistence (i.e. prop-
agation) of these complexes in vivo is also absolutely essential to realize their physiological con-
sequences. In contrast to amyloid formation, the molecular basis of amyloid propagation is far
less well understood. For example, a computational study aimed at identifying prion proteins
in the yeast proteome based on sequence characteristics effectively predicted proteins capable
of self-assembling into SDS-resistant aggregates, a hallmark of the amyloid state. However,
only a small subset of these aggregation-prone proteins could support inheritance of an amy-
loid reporter-based phenotype [12], indicating our limited ability to predict the persistence of
these complexes in vivo.
Nonetheless, some insight into the protein characteristics that support amyloid propagation
has been gleaned from extensive analysis of the yeast prion protein Sup35, a translation release
factor that can access a heritable amyloid state known as [PSI+] in vivo [2]. The Sup35 protein
contains a bipartite N-terminal prion-determining domain (PrD) composed of a Q/N-rich
region (amino acids 1–41) followed by five and a half imperfect oligopeptide repeats (amino
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acids 42–97) with the consensus sequence PQGGYGGYN [13]. The Q/N-rich region is
required for and confers specificity to the aggregation [14,15], but this region alone is not suffi-
cient to induce or sustain [PSI+] in vivo [16,17]. Instead, these activities depend on the oligo-
peptide repeat region [16–25]. The addition of the first repeat to the Sup35 Q/N-rich region
allows the protein to join existing amyloid aggregates composed of full-length Sup35 in vivo,
but five repeats, in addition to the Q/N-rich region, are required for prion propagation in the
absence of full-length Sup35 [16,17]. Consistent with these observations, the addition of the
Sup35 oligopeptide repeats converted an aggregation-prone polyglutamine track (Q62) to a
heritable prion [16], demonstrating that the essential function of the oligopeptide repeats in
prion propagation is transferrable.
The number of Sup35 oligopeptide repeats has also been implicated in the stability of the
non-prion [psi-] state in vivo. Deletion of four repeats leads to a decrease in the spontaneous
frequency of [PSI+] appearance, while the introduction of two additional repeats leads to an
increase in the spontaneous frequency of [PSI+] appearance in vivo, with both changes contrib-
uting a two-order-of-magnitude effect [21]. Both the repeat deleted and expanded proteins
retain the ability to form amyloid in vitro, albeit at different rates, suggesting that the contribu-
tion of the repeats to prion propagation in vivo cannot be explained solely by aggregation pro-
pensity [21].
The mammalian prion protein, PrP, also contains five oligopeptide repeats, four with the
sequence PHGGGWGQ and a fifth with the sequence PQGGGTWGQ [26,27]. In humans,
expansion of the repeats, ranging from a single to twelve additional copies, is associated with
neurodegenerative disease [28,29]. Paralleling the observations of [PSI+] appearance in yeast,
the age of onset of neurodegenerative disease in humans correlates inversely with the number
of PrP repeats [30–32]. Intriguingly, PrP repeats can substitute for the essential function of
Sup35 oligopeptide repeats in the maintenance of [PSI+] in yeast, indicating functional overlap
[17,33,34].
Despite this functional significance and evolutionary conservation [35], the exact mecha-
nism by which Sup35 oligopeptide repeats, and by extension PrP repeats, promote prion prop-
agation in vivo is poorly understood. To date, three models, which are not mutually exclusive,
have been proposed. First, repeats may promote the conversion of soluble protein to the amy-
loid state, an idea that is consistent with the increased accumulation of soluble Sup35 upon
repeat deletion [36]. Second, repeats may stabilize Sup35-Sup35 interactions outside of the
conversion interaction, which dictates the amyloid core [17]. Consistent with this model,
repeat sequences have been shown to mediate Sup35-Sup35 interactions and to be partially
protected from solvent exchange in amyloid fibers in vitro [37–39]. Finally, repeats may facili-
tate chaperone interactions by serving as direct binding sites or by altering the conformation of
the amyloid to allow chaperone access [16], a prediction that is supported by the observation
that changes in aggregate size, an attribute linked to chaperone processing [40], inversely corre-
late with repeat number [36].
Distinguishing among these models has been challenging. Previous studies have relied on
steady-state observations, but prion propagation in yeast is a multistep process that requires
prion protein synthesis, its conversion to the amyloid state via interaction with existing amy-
loid, the fragmentation of growing amyloid aggregates by molecular chaperones, and the trans-
mission of these complexes to daughter cells [2].
Here, we address the specificmechanistic contributions of the Sup35 oligopeptide repeats to
prion propagation in vivo. We find that this region is composed of two functional elements, the
oligopeptide repeats themselves and a downstream region, which we refer to as the repeat prox-
imal region (RPR). Without significantly altering the kinetic stability of the amyloid state, the
presence of the oligopeptide repeats and the RPR primarily promote chaperone-mediated
Mechanism of Prion Sequence Element Action
PLOS Genetics | DOI:10.1371/journal.pgen.1006417 November 4, 2016 3 / 30
fragmentation of Sup35 aggregates. But, these elements likely act through distinct mechanisms,
with the RPR promoting chaperone binding, and the oligopeptide repeats promoting chaper-
one processing.
Results
Oligopeptide repeats act synergistically with a newly identified sequence
element to enhance the severity of the [PSI+] phenotype
Wildtype Sup35 contains five and a half oligopeptide repeats [41,42]. But, previous analyses of
their contribution to prion propagation in vivo used deletion constructs that also removed the
RPR, a downstream asparagine-rich region (amino acids 98–111, RGNYKNFNYNNNLQ).Thus,
the potential contributions of each element to prion propagation have not been disentangled.
To separately assess the contribution of the Sup35 oligopeptide repeat region to [PSI+] prop-
agation in vivo, we constructed a series of yeast strains expressing repeat sequence variants
(RVs), composed of full-length Sup35 containing a different number of repeats (Fig 1A). This
collection includes repeat deletion strains (R1-X), which contain the N terminal X repeats,
from 2 to 5, and repeat expansion strains (R2E1 and R2E2), which contain one or two extra
copies of the second repeat for a total of 6.5 or 7.5 repeats, respectively. The RVs replaced the
wildtype copy of Sup35 at the endogenous locus and were expressed from the Sup35 promoter
to wildtype levels (S1A Fig). However, using this same configuration, the repeat expansion var-
iants (R2E1 and R2E2) were expressed at a much lower level. Thus, we integrated a second
copy of the repeat expansion proteins expressed from the SUP35 (R2E1) orMFA1 (R2E2) pro-
moters at another locus in these strains to raise their expression to wildtype levels (S1A Fig).
Because the extent to which this region of the protein is buried in the fiber interface varies
based on the conformation of the protein in the amyloid [37], we have restricted our analysis
to the [PSI+]Strong variant of Sup35.
To assess the prion phenotypes of our RV strains, we took advantage of the premature ter-
mination codon (PTC) in the ADE1 gene in our yeast strain background (the ade1-14 allele),
which provides a sensitive reporter of Sup35 translation release factor activity in vivo [43]. Sol-
uble non-prion Sup35 promotes efficient translation termination at the PTC in [psi-] strains,
while aggregated Sup35 in [PSI+] strains is functionally compromised, allowing read through
of the PTC. These differences in Ade1 expression cause [psi-] strains to form red colonies on
rich medium and block their growth on minimal medium lacking adenine, while [PSI+] strains
form white colonies on rich medium and can grow on minimal medium lacking adenine [44].
Changes in [PSI+] propagation efficiency, which lead to the accumulation of increased soluble
and decreased aggregated Sup35, result in the formation of pink colonies on rich medium and
partial growth on medium lacking adenine [45].
The phenotypes of strains containing four, five, or the wildtype number of repeats were
nearly indistinguishable on rich medium (Fig 1B), but the strain expressing R1-4 lost the [PSI+]
prion at a frequency of ~3%, while [PSI+] was fully stable in the other strains. When the number
of repeats was reduced, the colonies grew slightly worse on medium lacking adenine compared to
the wildtype strain (Fig 1B). In contrast, when the number of repeats was expanded, the colonies
appeared more white on rich medium and grew slightly better on medium lacking adenine, indi-
cating more efficient stop codon read-through (Fig 1B). Repeat deletion strains containing only 2
or 3 repeats (R1-2 and R1-3, respectively) were unable to support [PSI+] (S1B and S1C Fig), indi-
cating that at least four repeats are required for prion maintenance.
Our observations are in conflict with previous studies, in which [PSI+] maintenance was
reported to require the presence of at least five repeats [16,17], suggesting the RPR may play a
role in prion propagation in vivo. Indeed, deletion of the RPR in our wildtype construct
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modestly reduced the strength of the [PSI+] phenotype, producing colonies that were more
pink on rich medium and that grew at a reduced rate on medium lacking adenine (Fig 1B).
This same trend was also apparent when the RPR was removed from the repeat deletion strains
(Fig 1B). Notably, while a construct containing only 4 repeats was unable to maintain [PSI+] in
the absence of the RPR, as previously reported [16,17], it regained the ability to do so in the
presence of the RPR (Fig 1B and S1D Fig). Thus, removal of the RPR enhances the prion prop-
agation defect caused by deletion of Sup35 repeats.
Fig 1. [PSI+] maintenance depends on two sequence elements in the oligopeptide repeat region. A. Schematic
diagram of repeat variant constructs. See text for abbreviations. B. Sequence variant strains (R1-4 (SY2057), R1-5
(SY2022), R2E1 (SY2247), R2E2 (SY2300), R1-4ΔRPR (SY1629), R1-5ΔRPR (SY1633), and ΔRPR (SY2023)) were
spotted onto rich medium (1/4 YPD), or medium lacking adenine (SD-Ade) to analyze the [PSI+] phenotype. Wildtype [psi-]
and [PSI+] strains (SLL2119 and SLL2606, respectively) are shown as controls.
doi:10.1371/journal.pgen.1006417.g001
Mechanism of Prion Sequence Element Action
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The repeats and RPR do not significantly alter conversion efficiency
The defect in prion propagation induced by deletion of the repeats or the RPR suggests a
change in some aspect of prion aggregate dynamics in vivo: conversion of soluble Sup35 to the
amyloid form and/or amyloid fragmentation by the molecular chaperones Hsp104, Hsp70
(Ssa1), and Hsp40 (Sis1) [2]. To identify the defects specific to each sequence variant, we first
characterized a subset of strains, which represented each type of alteration: R1-5 (repeat dele-
tion), R2E1 (repeat expansion), and ΔRPR (RPR deletion). For the repeat deletions and expan-
sions, we first chose the most conservative changes to minimize toxicity, as doubling times
increasedwith more severe changes in the number of these sequence elements (Table 1).
Using these strains, we first directly monitored the conversion of soluble Sup35 to the amy-
loid state using a fluorescent read-through assay, which reports on the defect in Sup35 transla-
tion release activity upon aggregation of the protein [46,47]. In this assay, [psi-] strains,
expressing one of the sequence variants and the read-through reporter GST(UGA)YFP-NLS,
were mated to a wildtype [PSI+] strain.While YFP is not initially expressed in the reporter
strain due to the absence of [PSI+], the conversion of the soluble Sup35 protein in the [psi-]
strain to the amyloid state upon mating to the [PSI+] partner leads to the accumulation of
nuclear fluorescence in the zygote (Fig 2A). As expected, in zygotes formed by crossing the R1-
5, ΔRPR, R2E1 or wildtype [psi-] strains to a wildtype [psi-] strain, nuclear fluorescencewas
low and nearly identical (Fig 2B, lanes 1–4), indicating that the Sup35 sequence variants in
these crosses remain soluble and functional. In contrast, when the R1-5, ΔRPR or wildtype
[psi-] strains were crossed to a wildtype [PSI+] strain, nuclear fluorescencewas higher than
seen in the cross to a wildtype [psi-] strain but was still similar among the three crosses (Fig 2B,
lanes 5–7), indicating that the Sup35 sequence variants containing a repeat or RPR deletion are
not significantly impaired in their ability to convert to the amyloid state. However, the R2E1
[psi-] X wildtype [PSI+] cross produced nuclear fluorescence intensity that was significantly
increased relative to the wildtype zygote (Fig 2B, compare lanes 5 and 8), suggesting, at face
value, that the repeat expansion may more readily convert to the amyloid form, an observation
consistent with the idea that the repeats promote conversion [36].
Because differences in amyloid fragmentation by molecular chaperones affect the accumula-
tion of templates and thereby the conversion efficiencyof soluble protein [48], we hypothesized
that the difference in nuclear fluorescence intensity observed in the R2E1 heterozygous zygote was
a downstream effect of an increase in fragmentation efficiency(i.e. more templates support more
conversion). To test this hypothesis, we repeated the wildtype and R2E1 [psi-] crosses to a wildtype
[PSI+] strain in the presence of guanidineHCl (GdnHCl), which inhibits Hsp104 activity, blocks
fragmentation, and reduces the number of amyloid templates [49,50]. In the presence of GdnHCl,
the nuclear fluorescence intensity was similar in zygotes produced by crossing either a wildtype or
R2E1 [psi-] strain with a wildtype [PSI+] strain (Fig 2C). Because the increased nuclear fluores-
cence intensity of the R2E1 strain was abolished uponHsp104 inhibition, we conclude that the
R2E1 protein converts to the aggregated state with similar efficiency to wildtype Sup35.
Table 1. Doubling times (in minutes) of repeat and RPR variant strains grown in rich medium.
[PSI+] [PSI+] + Sup35C
RWT 97.7 ± 4.1 96.4 ± 0.8
ΔRPR 99.5 ± 0.6 n.a.
R1-4 126.5 ± 1.5 97.9 ± 2.1
R1-5 99.1 ± 3.2 n.a.
R2E1 112.3 ± 2.6 n.a.
R2E2 166.0 ± 1.4 n.a.
doi:10.1371/journal.pgen.1006417.t001
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Fig 2. Neither Sup35 repeats nor the RPR impact the efficiency of prion conversion. A. Schematic representation of conversion mating assay.
Wildtype [psi-] strain containing the read-through reporter GST(UGA)YFP-NLS (SY2393) was mated to wildtype [PSI+] (SLL2606, top) or [psi-] (SY2119,
bottom). Ball and sticks represent soluble non-prion Sup35; pinwheels represent prion Sup35 amyloid. B. Wildtype (SY2393), R1-5 (SY2461), ΔRPR
(SY2463), and R2E1 (SY2465) [psi-] strains containing the read-though reporter GST(UGA)YFP-NLS were mated to wildtype [psi-] or [PSI+] (SLL2119
and SLL2606, respectively). Nuclear fluorescence intensity of zygotes was quantified. Horizontal lines on boxes indicate 25th, 50th, and 75th percentiles.
Whiskers indicate 10th and 90th percentiles. n21, *p = 10−23,student’s t-test. C. Wildtype (SY2393) and R2E1 (SY2465) strains containing the read-
through reporter GST(UGA)YFP-NLS were mated to wildtype [PSI+] (SLL2606) in the presence of guanidine HCl (GdnHCl). Nuclear fluorescence
intensity of zygotes was determined. Box plots are as described in panel B. n38, n.s. not significant.
doi:10.1371/journal.pgen.1006417.g002
Mechanism of Prion Sequence Element Action
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The repeats and RPR act at the fragmentation step of prion propagation
While the striking and Hsp104-dependent increase in nuclear fluorescence observed in the
R2E1 [psi-] X wildtype [PSI+] cross did not obviously correspond to conversion propensity, it
did suggest that the R2E1 amyloid was fragmented at an increased efficiency relative to the
wildtype and RV deletion amyloids (Fig 2B and 2C). If true, we would expect the R2E1 protein
to accumulate more and smaller aggregates at steady-state, and this increase in template num-
ber would in turn decrease the level of soluble Sup35 at steady-state. Indeed, by semi-denatur-
ing detergent agarose gel electrophoresis (SDD-AGE) [51], the R2E1 protein accumulated in
smaller SDS-resistant aggregates than wildtype Sup35 (Fig 3A), and this change correlated with
a decrease in SDS-sensitive (i.e. soluble) R2E1 protein in comparison with wildtype Sup35 (Fig
3B). This decrease in soluble protein in the R2E1 strain should also induce a more severe trans-
lation termination defect, a prediction consistent with its colony-based phenotypes: whiter on
rich medium and more robust growth on medium lacking adenine (Fig 1B).
Surprisingly, we could not detect an increase in heritable R2E1 aggregates (known as propa-
gons) using a genetic assay based on the transfer of existing aggregates to daughter cells in the
absence of fragmentation [52] (Fig 3C). We reasoned that this observation could be explained
by the fact that the shift in the size distribution of R2E1 aggregates was slight relative to wild-
type Sup35 (Fig 3A) and therefore beyond the sensitivity of this genetic-based assay. But, simi-
lar analyses of the R2E2 strain demonstrated a more severe shift in size to smaller SDS-
resistant aggregates by SDD-AGE (Fig 3A), a further decrease in SDS-sensitive protein (Fig 3B)
and a corresponding increase in propagons (Fig 3C). Thus, expansion of the number of repeats
in the Sup35 protein likely promotes amyloid fragmentation.
Consistent with this idea, deletion of repeats 4 and 5 in the context of R2E2, which returns
the total number of repeats to 5.5, shifts the steady-state size of Sup35 aggregates to a near wild-
type distribution (S1A and S1E Fig), suggesting that repeat number rather than identity is the
dominant force in amyloid fragmentation. If true, deletion of repeats below the wildtype num-
ber should further decrease amyloid fragmentation. To assess this prediction, we performed
similar analyses on the R1-5 strain, which removed one repeat and decreased the efficiencyof
[PSI+] propagation in vivo (Fig 1). Surprisingly, the steady-state size distribution of aggregates
(Fig 3A), the level of soluble protein (Fig 3B), and the number of propagons (Fig 3C) were
indistinguishable between the R1-5 and wildtype strains.
Given our observations of progressive effects in the repeat expansion strains, we next ana-
lyzed the size distribution of aggregates in the R1-4 strain, which removed one additional
repeat from R1-5 (Fig 1A). Rather than observing a simple shift in aggregates to a larger size
distribution, we observed a broadening of entire size distribution when R1-4 aggregates were
analyzed by SDD-AGE (Fig 3A). In contrast to the wildtype strain, [PSI+] propagated by the
R1-4 protein induces a strong extension of the strain doubling time (Table 1), suggesting it is a
toxic state that could indirectly alter amyloid dynamics through changes in protein homeosta-
sis (proteostasis) [53]. To circumvent this possibility, we expressed, in the R1-4 strain, the
domain of Sup35 that functions in translation termination (amino acids 254–685; Sup35-C),
which had been previously demonstrated to relieve the toxicity induced by overexpression of
the Sup35 prion domain (amino acids 1–253; Sup35-NM) [54]. Expression of Sup35-C elimi-
nated the toxicity of [PSI+] propagated by the R1-4 protein (Table 1), and the R1-4 protein
accumulated in larger aggregates than those of the wildtype protein in a [PSI+] strain that also
expressed Sup35-C (Fig 3D). This observation is consistent with the idea that deletion of
repeats decreases the efficiencyof fragmentation in vivo.
We next assessed the effects of deletion of the RPR on fragmentation, given its synergistic
effects on [PSI+] propagation with repeat deletions (Fig 1B). In the context of a wildtype
Mechanism of Prion Sequence Element Action
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number of repeats, deletion of the RPR slightly shifted the aggregate size distribution to larger
complexes (Fig 3E). This change in size did not significantly alter the number of propagons (Fig
3C), perhaps again reflecting the limited sensitivity of the assay, but it did increase the accumula-
tion of soluble ΔRPR protein in comparison with wildtype (Fig 3B). These observations, in com-
bination with the direct demonstration that the ΔRPR protein converts to the aggregated state
with an efficiency that is not significantly different fromwildtype (Fig 2B), suggest that RPR dele-
tion reduces the number of amyloid templates and therefore the efficiencyof fragmentation.
Because deletion of the RPR exacerbated the effects of repeat deletion on [PSI+] propagation
(Fig 1B), we reasoned that the ΔRPR protein might sensitize our assays to more directly reveal
Fig 3. Sup35 repeats and RPR promote amyloid fragmentation. A. SDD-AGE was performed on R1-4 (SY2057), R1-5 (SY2022), wildtype
[PSI+] (SLL2606), R2E1 (SY2247), R2E2 (SY2300) lysates, followed by immunoblotting for Sup35. B. Cell lysates from wildtype [PSI+]
(SLL2606), R2E1 (SY2247), R2E2 (SY2300), R1-5 (SY2022), ΔRPR (SY2023), and R1-5ΔRPR (SY1633) were incubated at 53˚C and 100˚C
in the presence of SDS before SDS-PAGE and immunoblotting for Sup35. The amount of soluble Sup35 was determined as the percentage of
signal at 53˚C relative to 100˚C. Bars represent means, error bars represent standard deviations. n5, *p<0.05, **p<0.01, student’s t-test. C.
The number of propagons in wildtype [PSI+] (SLL2606), R2E1 (SY2247), R2E2 (SY2300), R1-5 (SY2022), ΔRPR (SY2023), and R1-5ΔRPR
(SY1633) strains was determined by an in vivo colony based dilution assay. Horizontal lines on boxes represent the 25th, 50th, and 75th
percentiles. Whiskers represent maximum and minimums. n13, *p<0.05, **p<0.01, student’s t-test. D. SDD-AGE was performed on
wildtype [PSI+] (SLL2606), wildtype [PSI+] expressing an extra copy of Sup35C (SY2466) and R1-4 expressing an extra copy of Sup35C
(SY2467) lysates, followed by immunoblotting for Sup35. Panels represent non-consecutive lanes run on the same gel. E. SDD-AGE was
performed on wildtype [PSI+] (SLL2606), ΔRPR (SY2023), R1-5 (SY2022), and R1-5ΔRPR (SY1633) lysates, followed by immunoblotting for
Sup35.
doi:10.1371/journal.pgen.1006417.g003
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a fragmentation defect for R1-5 amyloid. Deletion of the RPR in the R1-5 protein did not shift
the distribution of aggregates to larger sizes beyond its effect in the wildtype protein (Fig 3E).
But, it did increase the soluble protein (Fig 3B, compare lanes 5 and 6) and decrease the num-
ber of propagons (Fig 3C, compare lanes 5 and 6) in comparison with deletion of the RPR
alone. Thus, removing a single half repeat is sufficient to reduce amyloid fragmentation effi-
ciency in the ΔRPR strain.
To directly assess the rate of amyloid fragmentation in vivo, we turned to a propagon ampli-
fication assay. In this assay, strains are grown in rich medium containing GdnHCl, which
reversibly inhibits Hsp104 [50], to reduce Sup35 aggregate number to the point just before
[psi-] cells appear in the population. Strains are then allowed to recover in rich medium in the
absence of GdnHCl, where the re-amplification of existing aggregates can occur upon Hsp104
reactivation [55]. The rate of this re-amplification had been previously linked to the product of
the conversion and fragmentation rates [55], but since our sequence variants have similar con-
version efficiencies (Fig 2B and 2C), this amplification rate provides a proxy for relative frag-
mentation rate.
Following release fromGdnHCl, individual cells were isolated at the indicated time points,
and the number of propagons per cell was determined. Importantly, the number of propagons in
each strain was similar prior to GdnHCl treatment (Fig 3C), and GdnHCl treatment similarly
reduced propagon number in all strains (Fig 4A–4C, 0 time point). The R1-5 protein subtly, but
reproducibly, recovers its propagon levels more slowly than wildtype (Fig 4A). For the ΔRPR and
R2E1 strains, propagon amplification is strongly and significantly different than wildtype, with
the ΔRPR strain having a reduced and the R2E1 strain supporting an enhanced rate of recovery
relative to the wildtype strain (Fig 4B and 4C). These activities are consistent with our observa-
tions at the colony (Fig 1B), protein (Figs 2B, 3A and 3B), and propagon (Fig 3C) levels.
While it is formally possible that these mutants differ from wildtype in their conversion effi-
ciencies to a degree that is undetectable by our fluorescence-basedassay (Fig 2), the predicted
changes in their efficiencies based on the shifts in steady-state size of Sup35 aggregates are
opposite of what would be predicted based on their rates of aggregate amplification. For exam-
ple, an increase in aggregate size (i.e. ΔRPR Fig 3E) should correspond to an increase in conver-
sion efficiency [40] and in turn an increase in amplification rate [55], predictions that are not
born out by our observations (Fig 4). Thus the combination of observations can be most parsi-
moniously reconciledwith a model in which the dominant contributions of both the repeats
and the RPR are to promote amyloid fragmentation in vivo.
To assess the impact of these sequence elements on fragmentation rates using another
method, we developed a mathematical model of aggregate amplification, capable of determin-
ing the basic reproductive number of aggregates (R0), which is the number of additional aggre-
gates produced by each aggregate in its lifetime, using a different experimental input
parameter: the steady-state level of soluble Sup35 (S1 Table). R0 is proportional to the fragmen-
tation rate (γ), when the rates of synthesis (α) and dilution (μ) and minimum aggregate size
(n0) are held constant (see Supplementary Materials). The repeat expansion (R2E2) had a
higher R0 and the RPR deletion had a lower R0 than wildtype Sup35 (Fig 4D and S2 Table),
consistent with a direct effect on rate of fragmentation or an inverse effect on the minimum
aggregate size, respectively. While we cannot rule out a change in n0 for these mutants relative
to wildtype, we also cannot explain the wholesale shifts in the steady-state size distributions of
the Sup35 aggregates for these mutants (Fig 3A) without a change in fragmentation [40]. As
was the case for the propagon amplification assay (Fig 4A), the wildtype and R1-5 strains could
not be distinguished by this method (Fig 4D and S2 Table). However, the R0 value for R1-
5ΔRPR was smaller than that of ΔRPR alone (Fig 4D and S2 Table), suggesting, that deletion of
the half repeat also reduced the rate of amyloid fragmentation in vivo.
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Fragmentation is catalyzed by the molecular chaperone Hsp104 [48,50,56–58], and Sup35
sequence elements impacting fragmentation efficiencywould therefore act through this cata-
lyst. As such, their deletion or expansion would be predicted to have distinct genetic interac-
tions with an Hsp104 mutant (Y662F) having a reduced efficiencyof substrate processing [59].
Specifically, Sup35 sequence changes that inhibit fragmentation should enhance the
Hsp104Y662F defect, while those that promote fragmentation should suppress the Hsp104Y662F
defect. As previously reported, Hsp104Y662F reduces the efficiencyof [PSI+] propagation by
wildtype Sup35 [60], leading to the formation of pinker colonies on rich medium, a reduced
growth rate on medium lacking adenine (Fig 5A), and a shift in aggregate distribution to larger
size by SDD-AGE (Fig 5B). This Hsp104Y662F defect was suppressed by the R2E1 protein,
which has a higher fragmentation rate in vivo (Fig 4C and S2 Table), both at the colony level
(Fig 5A) and by aggregate size (Fig 5B). In contrast, the Hsp104Y662F defect was enhanced by
deletion of prion domain sequence elements. Both the R1-5 and ΔRPR strains form colonies
that are more pink on rich medium and that are unable to grow on medium lacking adenine in
Fig 4. Sequence variant strains differ in their ability to amplify Sup35 amyloid. A. Wildtype [PSI+] (SLL2606) and R1-5 (SY2022) strains were
grown in YPAD + 3mM GdnHCl until nearly cured, followed by growth in YPAD for the indicated times. At each time point, the number of propagons
per cell was determined. Horizontal lines on boxes indicate 25th, 50th, and 75th percentiles, and whiskers indicate maximum and minimum. n4. B.
Wildtype [PSI+] (SLL2606) and ΔRPR (SY2023) strains were treated as in A. n4, *p<0.05, **p<0.01, student’s t-test. C. Wildtype [PSI+]
(SLL2606) and R2E1 (SY2247) strains treated as in A. n4, **p<0.01, students t-test. D. Mathematical modeling was used to calculate the R0
value for the indicated strains using the steady-state soluble Sup35 levels (Fig 3B). Box plots are as described in panel A. Statistical analysis is
described in the Supplementary Materials.
doi:10.1371/journal.pgen.1006417.g004
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the presence of Hsp104Y662F (Fig 5A), and aggregates of these proteins are shifted to larger size
distributions in the presence of Hsp104Y662F (Fig 5B). The latter effect is especially dramatic
for the RPR deletion, where Hsp104Y662F nearly eliminates Sup35 amyloid (Fig 5B). Taken
together, our data indicate that the repeat and RPR regions function in the Sup35 protein to
promote amyloid fragmentation.
Sup35 sequence variants do not interfere with [PSI+] propagation
through significant changes in the expression of fragmentation
chaperones or the physical properties of aggregates
Having identified fragmentation as the dominant step of prion propagation that is impacted by
the repeats and the RPR, we next sought to determine the mechanism by which these sequence
elements act. Because expression of the more extensive repeat expansion and deletion con-
structs was toxic (Table 1), we first considered the possibility that the sequence variants might
induce a stress response, resulting in altered chaperone levels, substrate load and amyloid frag-
mentation [61–63]. However, the expression levels of Hsp104 and its co-chaperones Ssa1
(Hsp70) and Sis1 (Hsp40) in our RV and ΔRPR strains were similar to wildtype (Fig 6A).
Therefore, changes in the levels of the chaperones that catalyze amyloid fragmentation are
unlikely to explain the differences in fragmentation efficiency in these strains.
We next considered the possibility that the repeats and the RPR may promote fragmenta-
tion by altering the kinetic stability of Sup35 amyloid, as has been observed for the Sup35
G58Dmutant [46,64]. Indeed, combined repeat and RPR truncations assemble into amyloid
Fig 5. Sup35 sequence variant strains show synergistic effects with an Hsp104 pore mutant. A. Sequence
variant strains expressing Hsp104WT (ΔRPR (SY2023), R1-5 (SY2022), RWT (SLL2606), R2E1 (SY2247)) or
Hsp104Y662F (ΔRPR (SY3004), R1-5 (SY3002), RWT (SY3001), and R2E1 (SY3005)) were spotted on rich
medium (1/4 YPD) and medium lacking adenine (SD-Ade) to analyze the [PSI+] phenotype. B. SDD-AGE was
performed on lysates from the strains described in A, followed by immunoblotting for Sup35.
doi:10.1371/journal.pgen.1006417.g005
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Fig 6. Sup35 repeat number and the RPR do not affect steady-state chaperone levels or aggregate kinetic
stability. A. R1-5ΔRPR (SY1633), R1-5 (SY2022), ΔRPR (SY2023), R2E1 (SY2247), R2E2 (SY2300) were
analyzed by SDS-PAGE and quantitative immunoblotting for Hsp104 (black), Ssa1 (gray), and Sis1(white). Bars
represent means; error bars represent standard deviations. n3. B. Lysates from R1-5 (SY2022), ΔRPR
(SY2023), wildtype [PSI+] (SLL2606), and R2E1 (SY2247) strains were incubated in 2% SDS at the indicated
temperatures before SDS-PAGE. The percent of Sup35 released from aggregates at each temperature was
determined relative to a sample incubated at 53˚C. Horizontal lines on boxes represent 25th, 50th, and 75th
percentiles. Whiskers represent maximums and minimums. n3.
doi:10.1371/journal.pgen.1006417.g006
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with higher kinetic stability when overexpressed [65]. However, the [PSI+] prion variant used
in that study was distinct from the [PSI+] strong strain used in these studies [36,65], and Sup35
sequence variants are known to confer conformation-specific effects on amyloid [64,66]. To
determine the kinetic stability of Sup35 amyloid in our strains, we assessed their solubility in
2% SDS over a range of temperatures by their ability to enter an SDS-polyacrylamidegel [67].
As the temperature was increased from 65°C to 80°C, the amount of SDS-soluble Sup35
increased, as expected [67,68], due to amyloid disassembly (Fig 6B). But across this tempera-
ture range, the amount of SDS-soluble R1-5, ΔRPR and R2E1 protein was similar to that of
wildtype Sup35 (Fig 6B). Thus, the changes in protein sequence did not significantly alter the
kinetic stability of amyloid or, by extension, their conformation.
The repeat region and the RPR alter the interaction between Sup35 and
molecular chaperones
Because the relative chaperone levels and kinetic stability of Sup35 amyloid are not significantly
altered in the repeat or RPR sequence variant strains, we next considered the possibility that
these sequence elements might promote fragmentation by affecting the efficiencywith which
Sup35 amyloid is recognizedor processed by molecular chaperones. We expressedHA-tagged
Sup35 prion domain (NM-HA) from the Sup35 promoter from a single-copy integrated con-
struct, using repeat and RPR variants of this fragment to match the full-length protein expressed
in each strain. Importantly, the NM-HA protein was expressed at similar levels in all strains (S1A
Fig). For the R1-5 and the R2E1 strains, the size of SDS-resistant aggregates was similar in the
presence (S2B Fig) and absence (Fig 3A) of NM-HA. However, for the ΔRPR strain, expression
of NM-HA eliminated the shift in SDS-resistant aggregate size (S2B Fig) that we observed in its
absence (Fig 3E), suggesting that expressing the prion domain as a separate fragment perturbs
amyloid dynamics in vivo. However, expression of the ΔRPR variant as an HA-tagged full-length
Sup35 (NM-HA-C) protein (S2C Fig) recapitulated the shift in the size distribution of SDS-resis-
tant aggregates to larger complexes by SDD-AGE (Fig 3E and S2D Fig).
Using quantitative co-immunocapture of the HA-tagged Sup35 sequence variants, similar
levels of Ssa1 and Sis1 were bound to the R1-5, R2E1, and wildtype proteins (Fig 7A and S3A
Fig). However, Hsp104 binding was altered by changes in repeat number. When repeats were
deleted (R1-5), slightly but significantly less Hsp104 was bound, but when repeats were
expanded (R2E1) the amount of boundHsp104 increased (Fig 7A and S3A Fig). For the ΔRPR
protein, binding to all three chaperones, Hsp104, Ssa1 and Sis1, was reduced by ~20% in com-
parison with wildtype Sup35 using the full-lengthHA-tagged protein (Fig 7B and S3B Fig).
Thus, chaperone binding correlates directly with fragmentation efficiency for the Sup35
sequence variants.
The RPR and repeat region make distinct contributions to substrate
outcomes in vivo
While our binding studies revealed that changes in both the repeats and the RPR alter the inter-
action of Sup35 with chaperones, their targets were distinct, with the number of repeats directly
correlating only with Hsp104 binding and deletion of the RPR lowering the binding of all three
chaperones (Fig 7A and 7B). Sup35 amyloid fragmentation is believed to be initiated by the
binding of these complexes to Sis1 and Ssa1 and their subsequent transfer to Hsp104 [69–71].
Thus, one interpretation of these observations is that the RPR promotes initial chaperone bind-
ing, but that once the amyloid is transferred to Hsp104, the repeats impact the efficiencywith
which Hsp104 processes this substrate, with lower processing corresponding to lower binding
at steady-state.
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If the primary function of the RPR is to promote initial chaperone binding, why would this
contribution become unnecessary in the context of the NM protein? In comparison with full-
Fig 7. Chaperone binding to Sup35 amyloid differs in sequence variant strains. A. NM-HA and co-aggregating full-
length (untagged) Sup35 in wildtype (SY3007), R1-5 (SY3008), and R2E1 (SY3010), strains were immunocaptured using
anti-HA magnetic beads and separated by SDS-PAGE, and the amount of bound chaperone proteins was quantified by
immunoblotting and corrected for the amount of Sup35 present in aggregates in each strain (see methods). Bars represent
means; error bars represent standard deviations, n4, *p<0.05, student’s t-test. B. NM-HA-C and co-aggregating full-length
Sup35 in wildtype (SY3159) and ΔRPR (SY3164) strains were immunocaptured with anti-HA magnetic beads and separated
by SDS-PAGE, and the amount of bound chaperones was quantified by immunoblotting and corrected for the amount of
Sup35 present in aggregates. Bars represent means; error bars represent standard deviations. n8, *p<0.05, **p<0.01,
student’s t-test. C. NM-HA and co-aggregating full-length (untagged) Sup35 in wildtype (SY3007) and ΔRPR (SY3009)
strains were immunocaptured with anti-HA magnetic beads and separated by SDS-PAGE, and the amount of bound
chaperones was quantified by western blot and corrected for the amount of Sup35 present in aggregates. Bars represent
means; error bars represent standard deviations. n = 4, **p<0.01, student’s t-test.
doi:10.1371/journal.pgen.1006417.g007
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length Sup35, the truncated prion domain completely lacks a stable, folded domain. As such, it
could be recognizedmore easily by the chaperone machinery, making the contribution of the
RPR less important. Indeed, more Ssa1, Sis1 and Hsp104 bound to ΔRPR NM-HA (Fig 7C and
S3A Fig) than to ΔRPR NM-HA-C (Fig 7B and S3C Fig). Thus, increasing chaperone binding
by removing the functional C-terminal domain can compensate for the ΔRPR prion propaga-
tion defect.
In light of this observation,we reasoned that we could distinguish between binding and pro-
cessing events by inserting the Sup35 prion domain fragments into another Hsp104 substrate.
If the Sup35 fragment impacted substrate processing efficiency, it should similarly affect
Hsp104 action on this substrate. However, if the Sup35 fragment promoted chaperone binding,
it may not affect Hsp104 action because the bona fide substrate already effectively recruits
chaperones in the absence of this fusion, in the same way that deletion of the RPR had no effect
in the context of the isolated prion domain (Fig 7C and S2B and S3A Figs). To test this idea, we
modified an existingmicroscopy-based assay, in which a folding sensor composed of firefly
luciferase fused to GFP is expressed in yeast cells, induced to misfold and aggregate by heat
shock, and allowed to disaggregate and refold during recovery at normal temperature in an
Hsp104-dependent manner [72,73].
Other members of AAA+ ATPase chaperone family, to which Hsp104 belongs, have been
shown to process substrates from either terminus or from internal sites [74]. To ensure that
effects would be visible regardless of the direction of processing, we included Renilla luciferase,
which misfolds and aggregates upon heat shock and is reactivated by Hsp104 (S4A Fig), in the
reporter. In this system, the N domain of Sup35 (amino acids 1–123) and its sequence variants
are inserted between the two luciferase proteins (Fig 8A). Importantly, both the levels of
reporter protein and activity in the absence of heat shock were identical for all of the variants
studied, indicating similar efficiencies of protein maturation and stability (S4B and S4C Fig).
Using a microfluidics chamber, we monitored the relative rate of recovery of reporters con-
taining the R1-4, ΔRPR, R2E2 and wildtype Sup35 N domains or lacking a Sup35 N insertion
at 30°C in the presence of cycloheximide following a sublethal heat shock at 40°C. For each
strain, the reporter protein coalesced into foci upon heat shock and resolved in an Hsp104-de-
pendent manner (Fig 8B and S4D and S5A Figs).
The addition of the Sup35N fragment reduced the rate at which foci were resolved (S5B Fig)
but did not decrease the amount of boundHsp104 (S5C Fig), suggesting that Hsp104 binding
was not limiting for substrate resolution. Consistent with this idea, the RPR, which promotes
initial chaperone binding to Sup35 but becomes unnecessary in the context of a misfolded pro-
tein capable of independently recruiting chaperones (Figs 3E, 7B and 7C, S2D Fig), can be
removed from the reporter without altering the rate of its resolution in comparison with the
reporter containing the intact N region (Fig 8B). In contrast, deletion of the repeats (R1-4),
which shifts the amyloid size to larger complexes consistent with a processing defect (Fig 3D),
resolved foci more slowly than wildtype (Fig 8B), and expansion of the repeats (R2E2), which
shifts the amyloid size to smaller complexes consistent with enhanced processing (Fig 3A),
resolved foci faster than wildtype (Fig 8B). Thus, our observations, together, are consistent
with the idea that the RPR promotes chaperone binding and that the repeats promote substrate
processing.
Discussion
While the oligopeptide repeat region of Sup35 had been previously implicated in “prion main-
tenance” [16], the precise mechanism by which it contributed to this process was not under-
stood. Through detailed analyses, we have separated the oligopeptide repeat region into two
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elements: the repeats themselves and a repeat proximal region.We uncovered no significant
contribution of either region to Sup35 conversion efficiency, aggregate kinetic stability, or
chaperone levels. While we cannot rule out minor changes in these attributes outside the limit
of detection for our assays, our studies suggest that the dominant role of these regions is to pro-
mote Sup35 amyloid fragmentation by molecular chaperones. This event has been previously
shown to be essential for prion propagation in vivo, necessary to create sufficient templates to
direct the conversion of soluble Sup35 to the amyloid state and to be transmitted to daughter
cells upon division [40,48]. Importantly, the two sequence elements appear to mediate func-
tional interaction of Sup35 amyloid with the chaperone machinery, through two separate activ-
ities. The repeat proximal region appears to mediate the binding of chaperones to Sup35
amyloid, while the repeats themselves appear to promote efficient chaperone processing of
these aggregates.
The RPR had been previously identified as a functional element in various in vitro studies of
Sup35 amyloid. This asparagine-rich region is predicted to be amyloidogenic on its own [75],
and it is partially protected from solvent exchange and labeling in Sup35 amyloid [37,38]. In
Fig 8. Sup35 repeats but not RPR exert transferrable effects on another Hsp104 substrate. A. Schematic
diagram of reporter construct. B. The indicated strains expressing luciferase reporter (RWT (SY2603), R1-4
(SY2666), R2E2 (SY2640), and ΔRPR (SY2637)) constructs were incubated at 37˚C for 30 minutes, followed by
40˚C for 35 minutes, with cycloheximide added for the last 10 minutes, in a microfluidics chamber. Cells were then
allowed to recover at 30˚C in the presence of cycloheximide, and images were taken at the indicated time points.
At each time point, the percentage of cells containing GFP foci was determined.
doi:10.1371/journal.pgen.1006417.g008
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addition, residues in the RPR have been shown to be in close proximity in neighboringmole-
cules in the Sup35 amyloid [38,76] and to be able to capture soluble Sup35 in vitro [39]. Finally,
the RPR contains a predicted binding site for Hsp70 [77] and binds to Hsp104 in vitro [78,79].
Nevertheless, deletion of the RPR alone had a mild phenotypic effect on [PSI+]-dependent stop
codon read-through in vivo and was not further characterized [17]. But, the synergistic effect
of the RPR and the repeats on fragmentation efficiency and their inadvertent linkage in previ-
ous studies, led this element to be overlooked in favor of the repeats. Our studies now indicate
that deletion of the RPR has a stronger effect on Sup35 amyloid dynamics than deletion of a
single repeat (Figs 1B, 3A, 3B, 4A and 4B) and that both elements contribute separate activities
to the efficiencyof amyloid fragmentation and thereby prion propagation in vivo.
Previous studies have suggested that the amino acid composition of the Sup35 oligopeptide
repeats, rather than their primary sequence per se, was the dominant contributor to prion prop-
agation [80]. In these studies, Sup35 mutants were generated by scrambling the sequence of the
repeat domain but leaving the amino acid composition intact. The fact that this sequence can
be scrambled and still support [PSI+] propagation, albeit to varying efficiencies [80,81], is
inconsistent with the region functioning as a primary binding site for molecular chaperones
[16]. However, the potential role that we have uncovered for the repeats in substrate processing
can be explained as a primary sequence independent event.
Hsp104 functions as a hexamer containing a central pore, through which substrates are
threaded and unfolded.Within this pore, conformational changes in flexible aromatic residues
provide the power stroke to drive substrate processing [82]. It is tempting to speculate that the
low sequence complexity of the repeats affects substrate threading, and thereby amyloid frag-
mentation, by providing few architectural elements with which Hsp104 can interact. In this
scenario, Hsp104 exerts an unfolding force as it processes Sup35, but it would disengage once it
reached the repeats. Because Sup35 remains aggregated, Hsp104 would iteratively attempt to
resolve these complexes, providing additional force that would ultimately lead to fragmenta-
tion. But, this outcome is also likely to be promoted by the inherent folding rate of the oligo-
peptide repeat region. Indeed, the processing of substrates by AAA+ ATPases in other systems
has been shown to be a competition between substrate unfolding by the enzyme and its ability
to refold in between each power stroke, with fast refolding requiring additional rounds of
engagement [83]. Consistent with this idea, R2E2 amyloid fibers, which have a higher fragmen-
tation rate in vivo, are able to quickly refold followingmechanical unfolding in vitro, whereas
repeat deletion (RΔ2–5) fibers cannot [84], differences which are likely to promote additional
rounds of engagement with Hsp104 for the former but not the latter substrate.
The idea that the oligopeptide repeats promote substrate processing is also consistent with
the existence of stop-transfer sequences in the substrates of other AAA+ ATPases: ClpXP and
the proteasome. For example, polyQ sequences have been demonstrated to decrease the proces-
sivity of the proteasome in a length dependent manner [85–87]. In addition, the transcription
factors NF-κB in higher eukaryotes and cubitus interruptus (Ci) in Drosophila both exist as
full-length inactive precursors in the cytosol. In response to the appropriate signals, these pre-
cursors are then partially degraded by the proteasome to produce active truncated products,
which then translocate to the nucleus and activate target gene transcription [88,89]. The partial
degradation of these proteins is dependent on a stretch of simple sequence.When the protea-
some reaches the simple sequence, the lack of architectural features reduces the amount of
force it can exert to thread the substrate. This reduced force, combined with the nearby tightly
folded domain, results in stalling of the proteasome and the release of a partially degraded
product [90,91]. A similar mechanism has been proposed to explain the activation of the yeast
transcription factors Spt23 and Mga2 as well as the immune evasion of the EBNA1 protein of
the Epstein-Barr virus [92,93].
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As an alternative scenario, specific amino acid residue(s) within the repeats may directly
promote fragmentation efficiency. For example, the repeats contain tyrosine residues, which
may promote interaction with the aromatic residues in the Hsp104 pore. Consistent with this
idea, addition of tyrosine residues to a polyQ protein, reduces the number of Q residues
required for the formation of SDS-resistant amyloids in vivo [94]. Importantly, this addition of
tyrosines is also associated with a shift in the steady-state size distribution of these amyloids to
smaller complexes, suggesting that the tyrosines facilitate fragmentation and thereby accumu-
lation of amyloid [94]. In this model, the requirement for a minimum number of repeats
would be interpreted as a threshold of tyrosine residues necessary to promote efficient frag-
mentation. Consistent with this idea, replacement of the tyrosines in repeats 3, 4 and 5 with
non-aromatic residues leads to [PSI+] loss in vivo, although progressive effects and the mecha-
nism by which this loss occurs were not assessed [95].
Interestingly, the number of repeats is generally conserved across a variety of amyloids. In
all yeast species in which the Sup35 homologue has been shown to be capable of forming a
prion in the S. cerevisiae cytoplasm, the Sup35 protein contains between five and six repeats
[17,96,97]. Similarly, PrP contains five copies of an octarepeat [26,27], and bacterial functional
amyloids maintain similar numbers of repeated elements, with CsgA containing 5 copies of a
hexapeptide repeat and FapC containing three copies of a repeat [98,99]. One possible explana-
tion for this similarity of repeat number across diverse species and proteins is evolutionary
optimization to allowmaintenance of both the amyloid and non-amyloid states. Our studies
suggest that fragmentation efficiency is the mechanism underlying the contributions of
repeated elements to these transitions.
While a mammalian AAA+ ATPase responsible for PrP amyloid fragmentation in vivo has
not been identified,mathematical models suggest that the kinetics of disease progression can
only be explained with a fragmentation event [100,101]. The ability of PrP repeats to function-
ally substitute for those of Sup35 in [PSI+] maintenance suggests that they could play a similar
role in mammals. Recent studies have identified potential candidates for this function, includ-
ing the AAA+ ATPase RuvbL [102] or the combination of Hsp70, DNAJB1, and Hsp110 [103],
although their contributions to mammalian prion propagation have not yet been addressed.
Together, our studies suggest specific roles for amino acid sequence and composition biases
in the propagation of a prion in vivo. Beyond conferring amyloid propensity, these characteris-
tics can mediate essential functional yet mechanistically distinct interactions with the cellular
chaperone machinery to promote the appearance and maintenance of alternative, self-replicat-
ing conformers in vivo. Their evolutionary conservation suggests a selection for these functions
[27,35], and their impact on the phenotypic consequences of amyloid suggests that they may
represent unique therapeutic targets.
Methods
Plasmids
All plasmids used in this study are listed in S3 Table; all oligos used in this study are listed in S4
Table. All plasmids generated by PCR were confirmed by sequencing.
Repeat deletion plasmids. Repeat deletions R1-2 (SB803), R1-3 (SB804), R1-4 (SB775),
R1-5 (SB776), and ΔRPR (SB777) were constructed by amplification of a BamHI/EcoRV Sup35
fragment with primers 5BamHISup35 and 3R1-2EcoRV, 3R1-3EcoRV, 3R1-4EcoRV, 3R1-
5EcoRV, and 3Sup35R1-6EcoRV respectively and using SLL6686 as a template. BamHI/EcoRV
fragments were inserted into SLL6686. R1-4ΔRPR (SB549) and R1-5ΔRPR (SB550) were con-
structed as previously described [17]. R2E2Δ4–5 (SB1008) was synthesized as a BamHI/BseRI
fragment (Genewiz) and inserted into SLL6686.
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Repeat expansion plasmids. R2E1 (SB787) was constructed by annealing oligos R2E1
insertF and R2E1 insertR, and insertion of the resulting product into the BstXI site of SLL6686.
R2E2 (SB859) was constructed by QuikChange (Stratagene) of SB787 with R2 BstXI QCF and
R2 BstXI QCR according to the manufacturer’s instructions, followed by insertion of annealed
oligos R2E1 insertF and R2E1 insertR into the remaining BstXI site. SB883 and SB884 were
constructed by insertion of the R2E1 and R2E2 ORFs, respectively, as an EcoRI/SacI fragment
into pRS303-PSUP35.
HA-tagged constructs. NM-3HA constructs containing R1-5, ΔRPR, and R2E1 were con-
structing by inserting a PstI/MscI fragment from SB776, SB777, or SB787 respectively into
SB653. NM-3HA-C constructs containing RWT, R1-5, and ΔRPR were constructed by inser-
tion of the BglII/SacI fragment from pRS426-PSup35NM-3HA-C (gift from J. Weissman) into
SB653, SB1040, SB1041, and SB1042 respectively.
Conversion read-throughplasmid. pRS304-PGPDGST(UGA)YFP-NLS was constructed
by replacing the DsRedNLS open reading frame in SB531 using EcoRI and ClaI sites. YFP-NLS
was generated as a PCR fragment using the primers 5EcoRI Citrine and 3ClaI CitrineNLS and
pKT140 (Addgene) as a template.
Dual Luciferase constructs. SB973, SB994, SB975, SB976, and SB985 contain the GPD
promoter driving firefly luciferase-Sup35N-Renilla Luciferase-GFPGAr. A three-repeat gly-
cine-serine linker separates each of the ORFs. ORFs for Firefly luciferase (XbaI/BamHI PCR
fragment generated using 5XbaI Firefly and 3BamHI Firefly), Sup35N (BamHI/BamHI PCR
fragment generated using 5BamHIGS3 Sup35N and 3BamHI Sup35N), Renilla luciferase
(BamHI/EcoRI PCR fragment generated using 5BamHIGS3 Renilla and 3 EcoRI Renilla), and
GFPGAr (EcoRI/XhoI PCR fragment generated using 5EcoRIGS3GFP and 3XhoIGAr GFP),
were inserted into SB237. For Sup35N Rwt, R1-4, R2E2, and ΔRPR, PCR templates were
SLL6686, SB775, SB859, and SB777 respectively. SB986 contains Renilla Luciferase-GFP, with
the open reading frames separated by a three-repeat glycine-serine linker. Renilla luciferase
(XbaI/EcoRI PCR fragment generated using 5XbaI Renilla and 3EcoRI Renilla), and GFP-GAr
(EcoRI/XhoI PCR fragment generated using 5EcoRIGS3GFP and 3XhoIGAr GFP) were
inserted into SB237 (pRS305-PGPD).
Strain Construction
All strains used in this study are listed in S5 Table and are strong [PSI+] derivatives of 74-D694
[104].
Repeat Variant Strains. SY2072 (R1-2), SY2073 (R1-3), SY2057 (R1-4), SY 2022 (R1-5),
SY1629 (R1-4ΔRPR), SY1633 (R1-5ΔRPR), SY2023 (ΔRPR), and SY2808 (R2E2Δ4–5) were
constructed by integration ofMluI-digested SB803, SB804, SB775, SB776, SB549, SB550,
SB777, and SB1008 respectively, selection on SD-Ura, followed by counter selection on 5-FOA.
Strains were screened for repeat number by PCR using 5Sup35Nrepck and 3Sup35repck, and
confirmed by sequencing and for endogenous levels of Sup35 expression. SY2247 (R2E1) was
constructed by integration ofMluI-digested SB787, selection on SD-Ura, and counter-selection
on 5-FOA, followed by integration of AfeI-digested SB883 and selection on SD-His. Strains
were screened for repeat number by PCR using 5Sup35Nrepck and 3Sup35repck, and con-
firmed by sequencing and for endogenous levels of Sup35 expression. SY2300 (R2E2) was con-
structed by integration ofMluI-digested SB859, selection on SD-Ura, and counter selection on
5-FOA, followed by integration of AfeI-digested SB883, followed by selection on SD-His. To
obtain endogenous levels of Sup35 expression, the promoter at the endogenous locus was
replaced with PMFA1 by integration of a PCR-generated cassette, using F4-PSup35 and
R2-PMFAI primers, with SB526 (pFA6a-KanMX6-PMFA1) as a template, and selection on YPD
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+G418. Strains were screened for repeat number by PCR using 5Sup35Nrepck and
3Sup35repck, and confirmed by sequencing and for endogenous levels of Sup35 expression.
[psi-] versions of repeat variant strains were made by curing the [PSI+] versions on YPD
+ 3mM guanidineHCl (GdnHCl), and selection for colony color. SY2466 and SY2467 were
constructed by integration of PpuMI digested SLL6682 into SLL2606, and SY2057 respectively,
selection on SD-Ura, and screening by colony color. [PSI+] was confirmed by SDD-AGE.
SY3007, SY3008, SY3009, and SY3010 were constructed by integration of PpuMI-digested
SB653, SB1040, SB1041, and SB1042 into SY2606, SY2022, SY2023, and SY2247 respectively.
SY3159, and SY3164 were constructed by integration of PpuMI-digested SB1091, and SB1093
into SY2606, and SY2023 respectively. Hsp104Y662F point mutation was introduced into
SLL3250 by delitto perfetto [105] to generate SY2991, which was subsequently mated to repeat
variant strains SLL2606, SY2022, SY2023, and SY2247 and tetrads were dissected to generate
SY3001, SY3002, SY3004, and SY3005 respectively.
Conversion strains. SY2393 was constructed by integration of PpuMI-digested SB910 in
SLL3250, selection on SD-Trp, and screening by fluorescence, followed by prion curing by
3mM guanidineHCl (GdnHCl) treatment. SY2461, SY2463, and SY2465 were constructed by
mating SY2393 to SY2215, SY2212, and SY2302 respectively, followed by sporulation, dissec-
tion and selection on SD–Trp. Repeat number in tetrads was screened by PCR using primers
5Sup35Nrepck and 3Sup35Nrepck.
Luciferase strains. SY2597, SY2603, SY2637, SY2640, SY2666, and SY2694 were con-
structed by integration of StuI-digested SB973, SB994, SB975, SB976, SB985, and SB986 and
respectively. Strains were screened by luminescence and fluorescence.Hsp104 disruptions
SY2620, SY2625, SY2651, SY2654, SY2679, and SY2703 were constructed by integration of a
PvuI/BamHIdigested fragment of pYABL5 (gift from S. Lindquist) into SY2597, SY2603,
SY2637, SY2640, SY2666, and SY2694 respectively and selection on SD-Leu.
Growth conditions
All strains were grown in rich medium supplemented with 3mM adenine (YPAD), unless oth-
erwise specified.Cultures were grown in a shaking incubator at 30°C and maintained at an
OD600 of less than 0.5 for at least 10 doublings to ensure exponential growth.
Protein Analysis
SDS-PAGE and quantitative immunoblotting were performed as previously described [106].
Semi-DenaturingDetergent Agarose Electrophoresis (SDD-AGE) was performed as previously
described [51].
Propagon Counts
The number of propagons per cell was determined by an in vivo colony-based dilution assay, as
previously described [52]. For propagon amplification experiments, cultures were first grown
in YPAD + 3mMGdnHCl for 12 hours. Then, cells were pelleted, resuspended in YPAD to an
OD600 of 0.1, and grown at 30°C. Propagon counts were then performed at the indicated
timepoints.
Conversion Assay
Cultures were grown in SD+2.5mM adenine overnight, collected by centrifugation and incu-
bated in medium conditioned by cells of the opposite mating type for one hour. Equal OD600
equivalents of each mating partner were then mixed and incubated on solid SD + 2.5mM
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adenine and allowed to mate for 4 hours at 30°C (where indicated, mating took place on solid
SD + 2.5mM adenine + 3mMGdnHCl). Cells were then resuspended in SD + 2.5mM adenine
and transferred to microscope slides for imaging.
Imaging
Imaging was performed in complete minimal medium supplemented with 2.5mM adenine and
2% glucose. Static images were obtained on a Zeiss Axio Imager M2 fluorescent light micro-
scope with a 100x objective.Microfluidics were performed on a Zeiss Axio ObserverZ1 using a
CellAsics microfluidics plate with temperature controls and media flow of 2 psi on a Y0C4
yeast perfusion plate (channel size 3.5–5μm). Fluorescence intensity was analyzed using the
Zen software package (Zeiss, Germany).
Immunocapture
For NM-HA and NM-HA-C immunocapture, native lysates were prepared as described [61],
and immunocapture was performed using anti-HA magnetic beads or anti-Myc magnetic
beads (Thermo Scientific Pierce). Co-captured proteins were resolved by SDS-PAGE and ana-
lyzed by western blotting for Sup35, HA (Roche), Hsp104 (Abcam), Ssa1 (gift from E. Craig),
and Sis1 (gift fromM. Tuite). The amount of Sup35 and NM-HA or NM-HA-C captured was
adjusted to reflect only the amount of Sup35 proteins present in aggregates in each strain, as
determined by incubating lysates at 53°C and 100°C in the presence of SDS and resolving the
protein on an SDS-PAGE gel. The percentage of protein in aggregates was then calculated as
the fraction of Sup35 that did not enter the gel at 53°C. The amount of each chaperone that
was co-captured was then compared to the amount of captured aggregated Sup35.
For Hsp104 binding to luciferase reporters, cells were incubated at 37°C for 30 minutes fol-
lowed by 40°C for 35 minutes, with the addition of cycloheximide to 100μg/mL for the last 10
minutes. Cell lysates were prepared, and immunocapture was performed as described [61],
except 600mMNaCl was used in lysis and wash buffers. Co-captured proteins were separated
by SDS-PAGE and analyzed by western blotting for Firefly luciferase (Sigma) and Hsp104
(Abcam).
Luciferase Recovery
Cultures were grown to an OD600 of 0.1 at 30°C, then incubated at 37°C for 30 minutes to
induce chaperone expression. Cultures were then incubated at 40°C for 25 minutes, followed
by addition of cycloheximide to 100μg/mL, and returned to 40°C for 10 minutes, followed by
recovery at 30°C. Cells were imaged at the indicated timepoints.
Supporting Information
S1 Fig. Sup35 expression levels are similar in all sequence variant strains. A. Lysates from
R1-2 (SY2072), R1-3 (SY2073), R1-4ΔRPR (SY1629), R1-4 (SY2057), R1-5ΔRPR (SY1633),
R1-5 (SY2022), ΔRPR (SY2023), R2E1 (SY2247), R2E2 (SY2300), and R2E2Δ4–5 (SY2808)
were analyzed by SDS-PAGE and quantitative immunoblotting for Sup35. Bars represent
means; error bars represent standard deviations. n3. B. R1-2 (SY2072), R1-3 (SY2073) were
spotted onto rich medium (YPD) and medium lacking adenine (-Ade) to analyze the [PSI+]
phenotype.Wildtype [PSI+] (SLL2606) is shown as a control. C. SDD-AGE was performed on
wildtype [PSI+] (SLL2606), R1-2 (SY2072), and R1-3 (SY2073) lysates, followed by immuno-
blotting for Sup35. Panels shown are non-consecutive lanes run on the same gel.D. SDD-AGE
was performed on R1-4 (SY2057) and R1-4ΔRPR (SY1629) lysates, followed by
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immunoblotting for Sup35. E. SDD-AGE was performed on wildtype [PSI+] (SLL2606),
R2E2Δ4–5 (SY2808), and R2E2 (SY2247) lysates, followed by immunoblotting for Sup35.
(TIF)
S2 Fig. Characterizationof strains used for immunocapture. A. Lysates from wildtype
(SY3007), R1-5 (SY3008), R2E1 (SY3010), and ΔRPR (SY3009) strains expressing NM-HA
were analyzed by SDS-PAGE and quantitative immunoblotting for HA (Bars represent means,
error bars represent standard deviations, n3). B. SDD-AGE was performed on lysates from
wildtype (SY3007), R1-5 (SY3008), R2E1 (SY3010) and ΔRPR (SY3009) strains expressing full-
length Sup35 (FL) and NM-HA and immunoblotted for Sup35 n3. C. Lysates from wildtype
(SY3159), and ΔRPR (SY3164) strains expressing full-length Sup35 (FL) and NM-HA-C were
analyzed by SDS-PAGE and quantitative immunoblotting for HA (Bars represent means, error
bars represent standard deviations, n3).D. SDD-AGE was performed on cell lysates from
wildtype (SY3159) and ΔRPR (SY3164), strains expressing full-length Sup35 (FL) and
NM-HA-C followed by immunoblotting for Sup35.
(TIF)
S3 Fig. Hsp104, Ssa1, and Sis1 bind to Sup35 containing repeat or RPR variants. A. Repre-
sentative gel from experiment quantified in Fig 7A. Aggregates in wildtype (SY3007), R1-5
(SY3008), R2E1 (SY3010), and ΔRPR (SY3009) strains expressing NM-HA and full length
Sup35 were immunocaptured using anti-HA magnetic beads and separated by SDS-PAGE and
the amount of bound chaperone proteins was determined by immunoblotting.B. Representa-
tive gel from experiment quantified in Fig 7B. Aggregates in wildtype (SY3159) and ΔRPR
(SY3164) strains expressing NM-HA-C and full length (untagged) Sup35 were immunocap-
tured with anti-HA magnetic beads and separated by SDS-PAGE, and the amount of bound
Hsp104, Ssa1, and Sis1 was determined by immunoblotting. Panels shown are non-consecutive
lanes run on the same gel. C.Wildtype (SY3159) strains expressing NM-HA-C and full-length
(untagged) Sup35 were treated as in A, and the amount of Hsp104, Ssa1, and Sis1 bound was
determined by immunoblotting. Panels shown are non-consecutive lanes run on the same gel.
(TIF)
S4 Fig. Recoveryof dual luciferase constructs following heat shock is dependent on
Hsp104. A. Strains containing Renilla luciferase-GFPwith or without an Hsp104 disruption
(SY2694 and SY2703, respectively) were grown in rich medium, heat shocked at 37°C for 30
min followed by 40°C for 35 minutes with cycloheximide added for the last 10 minutes, and
allowed to recover at 30°C in the presence of cycloheximide.Renilla luciferase activity was mea-
sured at the indicated time points. n = 3, data represent means; error bars indicate standard
deviations.B. Lysates from strains containing Firefly-Sup35N-Renilla-GFP reporters were ana-
lyzed by SDS-PAGE and quantitative immunoblotting for GFP. n = 3, bars represent means;
error bars represent standard deviations.C. The levels of firefly and Renilla luciferase activity
were determined in strains expressing the indicated reporters. n = 3, bars represent means;
error bars represent standard deviations.D. Strains containing firefly luciferase-Sup35N(RV)-
Renilla luciferase-GFPwith or without an Hsp104 disruption were treated as in A, and imaged
at the indicated time points. Representative images are shown, scale bar = 5μm.
(TIF)
S5 Fig. Insertion of Sup35N in dual luciferase reporter delays substrate processing A. A
[psi-] strain containing firefly luciferase-Renilla luciferase-GFPwith (SY2620) or without
(SY2603) an Hsp104 disruption were grown in rich medium, heat shocked at 37°C for 30 min
followed by 40°C for 35 minutes with cycloheximide added for the last 10 minutes, and allowed
to recover at 30°C in the presence of cycloheximide, and imaged at the indicated time points.
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Representative images are shown. Scale bar = 2μm. B. The indicated strains expressing the dual
luciferase reporter without (SY2597) and with (SY2603) Sup35N were incubated at 37°C for 30
minutes, followed by 40°C for 35 minutes, with cycloheximide added for the last 10 minutes, in
a microfluidics chamber. Cells were then allowed to recover at 30°C in the presence of cyclo-
heximide, and images were taken at the indicated time points. At each time point, the percent-
age of cells containing GFP foci was determined. n38. C.Dual luciferase reporter fusion
proteins without (SY2597) and with (SY2603) Sup35N were immunocaptured, separated by
SDS-PAGE and the amount of boundHsp104 was quantified by western blot. n = 6, bars repre-
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